Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The fragment does not activate the growth hormone receptor or stimulate IGF-1 production
Retatrutide is an investigational peptide drug currently under clinical development by Eli Lilly
Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome in aging
The table below contains the most recent third-party analyses for all manufacturers and peptides listed on Peptide Partners
US$ 29.29
US$ 27.40
US$ 23.95
US$ 21.48
US$ 27.44
US$ 27.69
US$ 27.56
US$ 21.14
